Successful Pulmonary Resection Combined with Chemotherapy for the Treatment of Mycobacterium avium Pulmonary Disease: A Case Report.
10.4046/trd.2003.54.6.621
- Author:
Won Jung KOH
1
;
O Jung KWON
;
Eun Hae KANG
;
Gee Young SUH
;
Man Pyo CHUNG
;
Hojoong KIM
;
Kwhanmien KIM
;
Nam Yong LEE
;
Joungho HAN
;
Tae Sung KIM
;
Kyung Soo LEE
Author Information
1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ojkwon@smc.samsung.co.kr
- Publication Type:Case Report
- Keywords:
Atypical mycobacteria;
Mycobacterium avium complex;
Lung diseases;
Thoracic surgery;
Korea
- MeSH:
Clarithromycin;
Drug Therapy*;
Humans;
Korea;
Lung Diseases*;
Mycobacterium avium Complex;
Mycobacterium avium*;
Mycobacterium*;
Nontuberculous Mycobacteria;
Thoracic Surgery
- From:Tuberculosis and Respiratory Diseases
2003;54(6):621-627
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The Mycobacterium avium complex (MAC) is the most common pathogen causing nontuberculous mycobacterial pulmonary disease. Despite the introduction of newer, more effective agents for the treatment of MAC, such as clarithromycin, the response to drug therapy in MAC pulmonary disease remains poor, and often frustrating. When MAC pulmonary disease has not been successfully eradicated using drug treatment alone, surgical management is still recognized to play a significant role. A case of MAC pulmonary disease, in a patient whose MAC disease was successfully treated by pulmonary resection, following the failure of drug therapy containing clarithromycin, is reported. To our knowledge, this is the first case report in Korea that the patient underwent a pulmonary resection for the treatment of MAC pulmonary disease.
